1. Home
  2. CPRI vs TXG Comparison

CPRI vs TXG Comparison

Compare CPRI & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Capri Holdings Limited

CPRI

Capri Holdings Limited

HOLD

Current Price

$20.42

Market Cap

2.9B

ML Signal

HOLD

Logo 10x Genomics Inc.

TXG

10x Genomics Inc.

HOLD

Current Price

$18.12

Market Cap

2.8B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
CPRI
TXG
Founded
1981
2012
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Apparel
Biotechnology: Laboratory Analytical Instruments
Sector
Consumer Discretionary
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
2.8B
IPO Year
2011
2019

Fundamental Metrics

Financial Performance
Metric
CPRI
TXG
Price
$20.42
$18.12
Analyst Decision
Buy
Hold
Analyst Count
14
14
Target Price
$26.50
$16.39
AVG Volume (30 Days)
3.8M
2.7M
Earning Date
02-03-2026
02-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,326,000,000.00
$642,823,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$2.18
$7.74
P/E Ratio
N/A
N/A
Revenue Growth
7.69
5.25
52 Week Low
$11.86
$6.78
52 Week High
$28.27
$23.56

Technical Indicators

Market Signals
Indicator
CPRI
TXG
Relative Strength Index (RSI) 33.58 52.14
Support Level $19.78 $17.26
Resistance Level $21.01 $19.43
Average True Range (ATR) 1.17 1.17
MACD -0.19 -0.28
Stochastic Oscillator 14.05 50.08

Price Performance

Historical Comparison
CPRI
TXG

About CPRI Capri Holdings Limited

Capri Holdings is a marketer, distributor, and retailer of upscale accessories and apparel in the Americas, Europe, and Asia. Michael Kors, Capri's original and largest brand by sales, offers handbags, footwear, and apparel through more than 700 company-owned stores, wholesale, and e-commerce. Jimmy Choo (acquired in 2017) is best known for women's luxury footwear. Its products are sold in more than 200 company-operated stores. John Idol has served as Capri's CEO since 2003.

About TXG 10x Genomics Inc.

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).

Share on Social Networks: